Gefitinib Impurity 14 (HCl salt)
- CAS1383952-42-8
- CatalogueRS-G012054
- FormulaC16H21Cl2N3O3
- MW374.26
IN STOCK
On this page
Product identification
| Product name | Gefitinib Impurity 14 (HCl salt) |
|---|---|
| Catalogue No. | RS-G012054 |
| CAS No. | 1383952-42-8 |
| Molecular formula | C16H21Cl2N3O3 |
| Molecular weight | 374.26 |
| Availability | In stock— dispatched in about 1–2 weeks |
| Standard type | Impurity Reference Standards |
| Drug substance | Gefitinib |
| Storage | Refer to the certificate of analysis (COA) supplied with each lot |
| Intended use | For laboratory and research use only. Not for human or veterinary use. |
What is stated on the certificate
Content and purity are assigned per lot and stated on the certificate of analysis issued for the batch you receive — they are not a catalogue-level figure. The certificate records the tests performed, the specification applied and the result obtained for that lot.
| Field | Basis |
|---|---|
| Identity | Spectroscopic and chromatographic methods appropriate to the material |
| Purity | Chromatographic purity, area normalisation unless stated otherwise |
| Assay / content | Mass balance, corrected for the stated volatiles and residue |
| Catalogue and batch numbers | RS-G012054 / batch number on the certificate |
| Retest date | Printed on the certificate for the lot supplied |
Frequently asked
What documentation is supplied with this lot?
A certificate of analysis (COA) is issued for the lot you receive. It records the catalogue number
RS-G012054 and the batch number, the tests performed, the
specification applied and the result obtained. A safety data sheet is supplied with the shipment.
Is the assigned value given on an “as is” basis?
Content and purity are stated per lot on the certificate of analysis, on an “as is” basis unless the certificate says otherwise. The analytical basis for the assigned value is stated on the certificate.
How should this material be stored?
Store as stated: Refer to the certificate of analysis (COA) supplied with each lot. Re-test before use beyond the retest date printed on the certificate.
Do you supply pack sizes other than those listed?
Pack sizes are confirmed with the quotation. Quantities beyond the standard pack sizes can be quoted — send the quantity you need with your enquiry.
Finding this standard
Buyers reach this compound by CAS number, by catalogue number, through the drug substance it belongs to, or through the type of standard it is. Those routes all start here:
- Other impurities of Gefitinib
- Impurity Reference Standards of this kind
- Documents for this item (COA, SDS)
- Certificate of analysis for RS-G012054
- Request a quotation for RS-G012054
Searching another way? Send the structure, a SMILES string or the pharmacopoeial name — a CAS number is not required for a non-compendial impurity. Write to sales@rssechem.com.
Other standards of Gefitinib
All 112 further standards are listed here — every link is in the page, not loaded later.
-
Gefitinib
CUSTOM SYNTHESISRS-G012065 -
Gefitinib hydrochloride
CUSTOM SYNTHESISRS-U013632 -
Gefitinib EP Impurity B HCl
IN STOCKRS-G012016 -
Gefitinib Impurity B
IN STOCKRS-G012032 -
Gefitinib Impurity C
IN STOCKRS-G012048 -
Gefitinib Impurity D
BACK ORDERRS-G012028 -
Gefitinib Impurity E
IN STOCKRS-G012031 -
Gefitinib Impurity F
IN STOCKRS-G012005 -
Gefitinib Impurity G
BACK ORDERRS-I003252 -
Gefitinib Impurity H
IN STOCKRS-G012007 -
Gefitinib Impurity I
CUSTOM SYNTHESISRS-I010119 -
Gefitinib Impurity K
IN STOCKRS-G012012 -
Gefitinib Impurity L
IN STOCKRS-G012034 -
Gefitinib Impurity O
CUSTOM SYNTHESISRS-G012050 -
Gefitinib Impurity P
IN STOCKRS-G012004 -
Gefitinib Impurity V
BACK ORDERRS-G012014 -
1,2-Dichlorobenzene in methanol
IN STOCKRS-U004730 -
2-Amino-4-methoxy-5-(3-morpholin-4-yl)propoxy)-benzoic acid methyl ester
IN STOCKRS-I004189 -
3,4-Difluoroaniline
IN STOCKRS-C002092 -
3,4-Dihydro-7-methoxy-4-oxoquinazolin-6-yl acetate
IN STOCKRS-G012022 -
4-((3-Chloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl Acetate
BACK ORDERRS-U060764 -
4-((4-fluorophenyl)amino)-7-methoxyquinazolin-6-ol
BACK ORDERRS-U014659 -
4-(3-Chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yl acetate hydrochloride
BACK ORDERRS-U060396 -
4-(3-chloropropyl)-4-(3-morpholinopropyl)morpholin-4-ium chloride
IN STOCKRS-G012223 -
4-(3-chloropropyl)morpholine
IN STOCKRS-C003101 -
4-(3-chloropropyl)morpholine hydrochloride
IN STOCKRS-C003077 -
4-Chloro-3-fluoroaniline
IN STOCKRS-C003056 -
4-Chloro-7-methoxyquinazolin-6-yl Acetate
IN STOCKRS-G012008 -
4-isopropoxy-7-methoxyquinazolin-6-yl acetate
CUSTOM SYNTHESISRS-G012189 -
4-methoxy-5-(3-morpholin-4-yl)propoxy)-2-nitro-benzoic acid methyl ester
CUSTOM SYNTHESISRS-P011419 -
5-Hydroxy-4-methoxy-2-nitrobenzoic acid
IN STOCKRS-P030117 -
6,7-dimethoxyquinazolin-4-yl acetate
IN STOCKRS-G012224 -
6-Hydroxy-7-methoxy-4(1H)-quinazolinone
IN STOCKRS-G012021 -
7-methoxy-4-(3-morpholinopropoxy)quinazolin-6-ol
CUSTOM SYNTHESISRS-G012219 -
7-methoxy-4-oxo-3,4-dihydroquinazolin-6-yl acetate
IN STOCKRS-G012102 -
Benzenamine, 4-chloro-2-fluoro (BSC)
CUSTOM SYNTHESISRS-U081855 -
Ethyl-2-amino-4-methoxy-5-(3-morpholin-4-ylpropoxy)benzoate
IN STOCKRS-U095012 -
Ethyl-4-methoxy-5-(3-morpholin-4-ylpropoxy)-2-nitrobenzoate
CUSTOM SYNTHESISRS-U095011 -
Gefitinib D3
CUSTOM SYNTHESISRS-G012066 -
Gefitinib Impurity VII
IN STOCKRS-G012009 -
Gefitinib Impurity VIII
IN STOCKRS-G012043 -
Gefitinib-d6
CUSTOM SYNTHESISRS-I003080 -
methyl 4-hydroxy-3-methoxy-5-nitrobenzenecarboxylate
IN STOCKRS-U082737 -
Methyl 5-hydroxy-4-methoxy-2-nitrobenzoate
IN STOCKRS-U082112 -
N'-(4-Amino-2-cyanophenyl)-N,N-dimethylformimidamide
IN STOCKRS-U057741 -
O-Desmorpholinopropyl Gefitinib
IN STOCKRS-G012006 -
Gefitinib Impurity 2
IN STOCKRS-G012045 -
Gefitinib Impurity 6
IN STOCKRS-Z412P0I -
Gefitinib Impurity 8 (379228-50-9)
IN STOCKRS-G012079 -
Gefitinib Impurity 24
IN STOCKRS-I001AFT -
Gefitinib Impurity 27
IN STOCKRS-G012060 -
Gefitinib Impurity 34
IN STOCKRS-G012002 -
Gefitinib Impurity 43
IN STOCKRS-G012001 -
Gefitinib Impurity 48
IN STOCKRS-Z398ABG -
Gefitinib Impurity 77
CUSTOM SYNTHESISRS-I001BSY -
Gefitinib Impurity 82
BACK ORDERRS-I001A7Z -
Gefitinib Impurity 82 CRS
IN STOCKRS-G012037 -
Gefitinib Impurity 91
IN STOCKRS-I001761 -
Gefitinib Impurity 94
IN STOCKRS-I001AG9 -
Gefitinib Impurity 95
CUSTOM SYNTHESISRS-G012036 -
Gefitinib Impurity 98
BACK ORDERRS-I001375 -
Gefitinib Impurity 100
IN STOCKRS-G012067 -
Gefitinib Impurity 109
IN STOCKRS-G012015 -
Gefitinib Impurity 112
CUSTOM SYNTHESISRS-G012019 -
Gefitinib Impurity 131
IN STOCKRS-G012062 -
Gefitinib Impurity 139
IN STOCKRS-G012072 -
Gefitinib Impurity 142
CUSTOM SYNTHESISRS-G012035 -
Gefitinib Impurity 144
IN STOCKRS-G012003 -
Gefitinib Impurity 145
IN STOCKRS-G012011 -
Gefitinib Impurity 146
IN STOCKRS-G012013 -
Gefitinib Impurity 147
IN STOCKRS-G012020 -
Gefitinib Impurity 148
IN STOCKRS-G012024 -
Gefitinib Impurity 149
IN STOCKRS-G012026 -
Gefitinib Impurity 150
CUSTOM SYNTHESISRS-G012046 -
Gefitinib Impurity 151
BACK ORDERRS-G012047 -
Gefitinib Impurity 152
BACK ORDERRS-G012052 -
Gefitinib Impurity 153
IN STOCKRS-G012061 -
Gefitinib Impurity 154
IN STOCKRS-G012063 -
Gefitinib Impurity 155
IN STOCKRS-G012070 -
Gefitinib Impurity 159
IN STOCKRS-G012068 -
Gefitinib Impurity 160
BACK ORDERRS-G012075 -
Gefitinib Impurity 191
IN STOCKRS-G012010 -
Gefitinib Impurity 192
IN STOCKRS-G012017 -
Gefitinib Impurity 193
BACK ORDERRS-G012018 -
Gefitinib Impurity 194
IN STOCKRS-G012023 -
Gefitinib Impurity 195
IN STOCKRS-G012025 -
Gefitinib Impurity 196
IN STOCKRS-G012027 -
Gefitinib Impurity 197
IN STOCKRS-G012029 -
Gefitinib Impurity 198
IN STOCKRS-G012030 -
Gefitinib Impurity 199
IN STOCKRS-G012038 -
Gefitinib Impurity 200
IN STOCKRS-G012039 -
Gefitinib Impurity 201
BACK ORDERRS-G012040 -
Gefitinib Impurity 202
CUSTOM SYNTHESISRS-G012041 -
Gefitinib Impurity 203
IN STOCKRS-G012042 -
Gefitinib Impurity 204
IN STOCKRS-G012044 -
Gefitinib Impurity 205
IN STOCKRS-G012049 -
Gefitinib Impurity 206
CUSTOM SYNTHESISRS-G012053 -
Gefitinib Impurity 208
IN STOCKRS-G012057 -
Gefitinib Impurity 209
IN STOCKRS-G012058 -
Gefitinib Impurity 210
IN STOCKRS-G012059 -
Gefitinib Impurity 211
IN STOCKRS-G012064 -
Gefitinib Impurity 212
IN STOCKRS-G012069 -
Gefitinib Impurity 213
IN STOCKRS-G012071 -
Gefitinib Impurity 214
IN STOCKRS-G012073 -
Gefitinib Impurity 215
CUSTOM SYNTHESISRS-G012074 -
Gefitinib Impurity 216
IN STOCKRS-G012077 -
Gefitinib Impurity 217
IN STOCKRS-G012078 -
Gefitinib Impurity 218
CUSTOM SYNTHESISRS-G012083 -
Gefitinib Impurity 262
IN STOCKRS-G012076
![Chemical structure of 4-(3-Chloro-4-fluorophenylamino)-7-methoxy-6-[3-(4-morpholinyl)propoxy]quinazoline dihydrochloride](/structures/w4/OHAYARNLYSPHOJ-UHFFFAOYSA-N.webp?v=8)
Pharmacopoeial names (EP, USP, BP, JP) are used for identification purposes only and do not imply endorsement by those bodies. This product is supplied for laboratory and research use only — not for human or veterinary use.